Variable NF-κB pathway responses in colon cancer cells treated with chemotherapeutic drugs

Temesgen Samuel(Tuskegee University), Upender Manne(University of Alabama at Birmingham)

BMC Cancer

August 18, 2014

10.1186/1471-2407-14-599

Cited by 36

Related Papers

The G2/M Regulator 14-3-3ς Prevents Apoptosis through Sequestration of Bax

|Journal of Biological Chemistry|2001|152

Camptothecin Induces PD-L1 and Immunomodulatory Cytokines in Colon Cancer Cells

|Medicines|2019|31

Prognostic value of loss of heterozygosity and sub-cellular localization of SMAD4 varies with tumor stage in colorectal cancer

|Oncotarget|2017|17

Interference with pathways activated by topoisomerase inhibition alters the surface expression of PD‑L1 and MHC I in colon cancer cells

|Oncology Letters|2022|12